and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Esperion Therapeutics Stock Price (Quote) NASDAQ:ESPR
$6.45 ( 1.42% ) Friday, 1st Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.84 | $6.70 | Friday, 1st Jul 2022 ESPR stock ended at $6.45. This is 1.42% more than the trading day before Thursday, 30th Jun 2022. During the day the stock fluctuated 5.72% from a day low at $6.12 to a day high of $6.47. |
| 90 days | $4.59 | $7.05 | |
| 52 weeks | $3.28 | $21.55 |
Historical Esperion Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-01 | $6.24 | $6.47 | $6.12 | $6.45 | 535 581 |
| 2022-06-30 | $6.55 | $6.61 | $6.18 | $6.36 | 754 913 |
| 2022-06-29 | $6.25 | $6.70 | $6.19 | $6.67 | 765 829 |
| 2022-06-28 | $6.46 | $6.69 | $6.08 | $6.27 | 648 842 |
| 2022-06-27 | $6.52 | $6.63 | $6.39 | $6.55 | 689 373 |
| 2022-06-24 | $6.38 | $6.59 | $6.32 | $6.47 | 1 218 036 |
| 2022-06-23 | $5.67 | $6.31 | $5.67 | $6.29 | 1 063 928 |
| 2022-06-22 | $5.66 | $5.99 | $5.55 | $5.65 | 729 532 |
| 2022-06-21 | $5.70 | $5.90 | $5.58 | $5.81 | 1 017 701 |
| 2022-06-17 | $4.91 | $5.64 | $4.84 | $5.60 | 1 947 097 |
| 2022-06-16 | $5.18 | $5.28 | $4.90 | $4.92 | 975 088 |
| 2022-06-15 | $5.26 | $5.39 | $5.01 | $5.33 | 1 205 811 |
| 2022-06-14 | $5.33 | $5.33 | $5.04 | $5.20 | 698 251 |
| 2022-06-13 | $5.24 | $5.33 | $5.03 | $5.31 | 688 350 |
| 2022-06-10 | $5.60 | $5.70 | $5.40 | $5.47 | 590 821 |
| 2022-06-09 | $6.03 | $6.09 | $5.70 | $5.73 | 672 498 |
| 2022-06-08 | $6.23 | $6.56 | $6.06 | $6.10 | 1 237 247 |
| 2022-06-07 | $5.78 | $6.20 | $5.78 | $6.20 | 597 685 |
| 2022-06-06 | $5.92 | $6.13 | $5.82 | $5.83 | 701 229 |
| 2022-06-03 | $5.45 | $5.83 | $5.45 | $5.83 | 702 733 |
| 2022-06-02 | $5.43 | $5.71 | $5.36 | $5.62 | 534 970 |
| 2022-06-01 | $5.72 | $5.74 | $5.28 | $5.42 | 879 272 |
| 2022-05-31 | $5.84 | $5.97 | $5.61 | $5.70 | 608 266 |
| 2022-05-27 | $5.51 | $5.85 | $5.38 | $5.80 | 563 256 |
| 2022-05-26 | $5.69 | $5.69 | $5.48 | $5.51 | 717 564 |
| 2022-05-25 | $5.78 | $5.79 | $5.46 | $5.63 | 818 533 |
| 2022-05-24 | $6.03 | $6.09 | $5.75 | $5.79 | 892 142 |
| 2022-05-23 | $6.35 | $6.49 | $6.15 | $6.18 | 745 911 |
| 2022-05-20 | $6.26 | $6.52 | $6.01 | $6.31 | 807 047 |
| 2022-05-19 | $5.98 | $6.29 | $5.97 | $6.18 | 874 431 |
| 2022-05-18 | $6.32 | $6.45 | $6.03 | $6.07 | 1 477 510 |
| 2022-05-17 | $5.97 | $6.56 | $5.83 | $6.52 | 1 808 305 |
| 2022-05-16 | $5.76 | $6.14 | $5.75 | $5.89 | 1 495 133 |
| 2022-05-13 | $5.32 | $5.81 | $5.17 | $5.78 | 1 277 865 |
| 2022-05-12 | $4.78 | $5.26 | $4.66 | $5.24 | 1 422 394 |
| 2022-05-11 | $5.12 | $5.12 | $4.78 | $4.83 | 1 559 976 |
| 2022-05-10 | $5.34 | $5.49 | $5.02 | $5.13 | 2 005 985 |
| 2022-05-09 | $5.41 | $5.52 | $5.19 | $5.33 | 1 462 024 |
| 2022-05-06 | $6.04 | $6.08 | $5.48 | $5.51 | 2 084 918 |
| 2022-05-05 | $6.56 | $7.05 | $6.08 | $6.12 | 5 877 575 |
| 2022-05-04 | $6.66 | $6.66 | $6.08 | $6.38 | 1 792 145 |
| 2022-05-03 | $5.80 | $6.56 | $5.69 | $6.53 | 2 362 476 |
| 2022-05-02 | $5.69 | $5.99 | $5.64 | $5.73 | 1 141 903 |
| 2022-04-29 | $5.50 | $5.74 | $5.48 | $5.68 | 1 158 794 |
| 2022-04-28 | $5.50 | $5.53 | $5.10 | $5.51 | 1 641 327 |
| 2022-04-27 | $5.21 | $5.59 | $5.12 | $5.46 | 1 735 381 |
| 2022-04-26 | $5.15 | $5.29 | $5.10 | $5.22 | 1 152 711 |
| 2022-04-25 | $4.78 | $5.22 | $4.71 | $5.20 | 1 283 887 |
| 2022-04-22 | $4.70 | $4.82 | $4.59 | $4.78 | 766 300 |
| 2022-04-21 | $4.80 | $5.11 | $4.68 | $4.77 | 986 400 |
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
